NCT05429658View on ClinicalTrials.gov

Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 27, 2019

Primary Completion Date

November 22, 2021

Study Completion Date

February 24, 2022

Conditions
Acute Ischemic Stroke
Interventions
DEVICE

Thrombectomy

The Route 92 Medical Reperfusion System is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within the internal carotid, middle cerebral, basilar and vertebral arteries.

Trial Locations (2)

1023

Auckland City Hospital, Auckland

8011

Christchurch Hospital, Christchurch

All Listed Sponsors
lead

Route 92 Medical, Inc.

INDUSTRY

NCT05429658 - Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System | Biotech Hunter | Biotech Hunter